DOI: 10.1128/AAC.01130-19
Article Information
PubMed
Published By
History
- Received June 4, 2019
- Returned for modification June 26, 2019
- Accepted July 9, 2019
- Published online September 23, 2019.
Copyright & Usage
Copyright © 2019 Mahérault et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (July 22, 2019).
- You are viewing the most recent version of this article.
Author Information
- Anne-Claire Mahéraulta,b,
- Harry Kemblea,
- Mélanie Magnana,
- Benoit Gacheta,
- David Rochec,
- Hervé Le Nagarda,
- Olivier Tenaillona,
- Erick Denamura,d,
- Catherine Brangera and
- Luce Landrauda,b
- aUniversité de Paris, IAME, UMR 1137, INSERM, Paris, France
- bAP-HP, Laboratoire de Microbiologie Hygiène, Hôpital Louis Mourier, Colombes, France
- cLaboratoire d’Analyse Bioinformatique en Génomique et Métabolisme, Institut de Génomique, Commissariat à l’Energie Atomique, Génoscope, CNRS-UMR 8030, Evry, France
- dAP-HP, Laboratoire de Génétique Moléculaire, Hôpital Bichat, Paris, France
- Address correspondence to Luce Landraud, luce.landraud{at}aphp.fr.
Citation Mahérault A-C, Kemble H, Magnan M, Gachet B, Roche D, Le Nagard H, Tenaillon O, Denamur E, Branger C, Landraud L. 2019. Advantage of the F2:A1:B- IncF pandemic plasmid over IncC plasmids in in vitro acquisition and evolution of blaCTX-M gene-bearing plasmids in Escherichia coli. Antimicrob Agents Chemother 63:e01130-19. https://doi.org/10.1128/AAC.01130-19.
